NCT00113724View on ClinicalTrials.gov

Study of TPI 287 in Patients With Advanced Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
NeoplasmsNon-Hodgkin LymphomaHodgkin Disease
Interventions
DRUG

TPI 287 Injection

Trial Locations (4)

10595

New York Medical College, Valhalla

80218

Rocky Mountain Cancer Center, Denver

85715

Arizona Clinical Research Center, Tucson

20007-2113

Georgetown University Medical Center/Lombardi Cancer Center, Washington D.C.

Sponsors
All Listed Sponsors
lead

Cortice Biosciences, Inc.

INDUSTRY

NCT00113724 - Study of TPI 287 in Patients With Advanced Malignancies | Biotech Hunter | Biotech Hunter